Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7

J O Lee1, A A Russo, N P Pavletich

  • 1Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Nature
|March 12, 1998
PubMed

Insights

The retinoblastoma (Rb) tumor suppressor's pocket domain is crucial for its function and is targeted by human papillomavirus E7 oncoprotein in cervical cancer. Structural analysis reveals how E7 binds Rb, offering insights into cancer mechanisms.

Area of Science:

  • Structural Biology
  • Molecular Oncology
  • Virology

Background:

  • The retinoblastoma (Rb) tumor suppressor protein regulates the cell cycle and is inactivated in many cancers.
  • The human papillomavirus (HPV) E7 oncoprotein is a key factor in cervical cancer development, primarily through its interaction with Rb.
  • Understanding the Rb-E7 interaction at a molecular level is critical for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the structural basis of the interaction between the retinoblastoma (Rb) protein pocket domain and the human papillomavirus (HPV) E7 oncoprotein.
  • To identify conserved binding sites and structural features involved in Rb-E7 complex formation.
  • To explore potential implications for understanding other Rb-binding proteins and their roles in cellular processes.

Main Methods:

  • X-ray crystallography was employed to determine the high-resolution structure of the Rb pocket domain bound to an E7 peptide.
  • Structural analysis focused on conserved motifs, binding interfaces, and similarities to other protein-binding sites.

Main Results:

  • The crystal structure reveals that the LxCxE motif within the E7 peptide binds to a conserved groove on the B-box of the Rb pocket domain.
  • The A-box of the Rb pocket domain is essential for the stable folding of the B-box.
  • The conserved A-B interface suggests a potential additional protein-binding site on the Rb pocket domain.
  • The LxCxE-binding site on the B-box exhibits structural similarities to cyclin-binding sites (e.g., Cdk2-binding site of cyclin A) and transcription factor-binding sites (e.g., TBP-binding site of TFIIB).

Conclusions:

  • The structural data provides a detailed molecular understanding of how HPV E7 inactivates the Rb tumor suppressor.
  • The findings highlight the importance of conserved structural features in protein-protein interactions involving the Rb pocket domain.
  • The identified similarities to other binding sites suggest that the Rb pocket domain may participate in diverse protein-interaction networks relevant to cell cycle regulation and cancer.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...